Cold Spring Harbor Laboratory announced a collaboration with the Chan Zuckerberg Initiative focused on the development and expansion of CSHL’s bioRxiv (pronounced “bio-archive”) preprint service, a free platform that enables life science researchers to quickly and easily share drafts of papers before they are published in peer-reviewed research journals.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
